Inflammatory Mediators Increase SUMOylation of Retinoid X Receptor α in a c-Jun N-Terminal Kinase–Dependent Manner in Human Hepatocellular Carcinoma Cells
Molecular Pharmacology, ISSN: 0026-895X, Vol: 84, Issue: 2, Page: 218-226
2013
- 20Citations
- 23Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations20
- Citation Indexes20
- CrossRef20
- 20
- Captures23
- Readers23
- 23
Article Description
Retinoid X receptor α [RXR α ; nuclear receptor (NR)2B1] is a crucial regulator in the expression of a broad array of hepatic genes under both normal and pathologic conditions. During inflammation, RXR α undergoes rapid post-translational modifications, including c-Jun N-terminal kinase (JNK)-mediated phosphorylation, which correlates with a reduction in RXR α function. A small ubiquitin-like modifier (SUMO) acceptor site was recently described in human RXR α, yet the contributors, regulators, and consequences of SUMO-RXR α are not well understood. Inflammation and other stressors alter nuclear receptor function in liver and induce SUMOylation of several NRs as part of proinflammatory gene regulation, but linkages between these two pathways in liver, or for RXR α directly, remain unexplored. We sought to determine if inflammation induces SUMOylation of RXR α in human liver-derived (HuH-7) cells. Lipopolysaccharide, interleukin-1 β, and tumor necrosis factor α (TNF α ) rapidly and substantially stimulated SUMOylation of RXR α. Two RXR α ligands, 9- cis retinoic acid (9cRA) and LG268, induced SUMOylation of RXR α, whereas both inflammation- and ligand-induced SUMOylation of RXR α require the K108 residue. Pretreatment with 1,9-pyrazoloanthrone (SP600125), a potent JNK inhibitor, abrogates TNF α - and 9cRA-stimulated RXR α SUMOylation. Pretreatment with SUMOylation inhibitors markedly augmented basal expression of several RXR α -regulated hepatobiliary genes. These results indicate that inflammatory signaling pathways rapidly induce SUMOylation of RXR α, adding to the repertoire of RXR α molecular species in the hepatocyte that respond to inflammation. SUMOylation, a newly described post-translational modification of RXR α, appears to contribute to the inflammation-induced reduction of RXR α -regulated gene expression in the liver that affects core hepatic functions, including hepatobiliary transport.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0026895X2403757X; http://dx.doi.org/10.1124/mol.113.085555; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84880611926&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23690070; https://linkinghub.elsevier.com/retrieve/pii/S0026895X2403757X; https://dx.doi.org/10.1124/mol.113.085555; https://molpharm.aspetjournals.org/content/84/2/218
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know